Fecal Occult Blood Testing Beliefs and Practices of U.S. Primary Care Physicians: Serious Deviations from Evidence-Based Recommendations

Division of Cancer Prevention and Control, Centers for Disease Control and Prevention, 4770 Buford Highway, MS K55, Atlanta, GA 30341, USA.
Journal of General Internal Medicine (Impact Factor: 3.42). 04/2010; 25(8):833-9. DOI: 10.1007/s11606-010-1328-7
Source: PubMed


Fecal occult blood testing (FOBT) is an important option for colorectal cancer screening that should be available in order to achieve high population screening coverage. However, results from a national survey of clinical practice in 1999-2000 indicated that many primary care physicians used inadequate methods to implement FOBT screening and follow-up.
To determine whether methods to screen for fecal occult blood have improved, including the use of newer more sensitive stool tests.
Cross-sectional national survey of primary care physicians.
Participants consisted of 1,134 primary care physicians who reported ordering or performing FOBT in the 2006-2007 National Survey of Primary Care Physicians' Recommendations and Practices for Cancer Screening.
Self-reported data on details of FOBT implementation and follow-up of positive results.
Most physicians report using standard guaiac tests; higher sensitivity guaiac tests and immunochemical tests were reported by only 22.0% and 8.9%, respectively. In-office testing, that is, testing of a single specimen collected during a digital rectal examination in the office, is still widely used although inappropriate for screening: 24.9% of physicians report using only in-office tests and another 52.9% report using both in-office and home tests. Recommendations improved for follow-up after a positive test: fewer physicians recommend repeating the FOBT (17.8%) or using tests other than colonoscopy for the diagnostic work-up (6.6%). Only 44.3% of physicians who use home tests have reminder systems to ensure test completion and return.
Many physicians continue to use inappropriate methods to screen for fecal occult blood. Intensified efforts to inform physicians of recommended technique and promote the use of tracking systems are needed.

Download full-text


Available from: Robert A Smith
  • Source
    • "Current guidelines recommend using a combination of FOBT or the newer FIT [18] and endoscopy [19]. We focus on endoscopy use in this paper because Medicare claims accurately capture these services but do not accurately capture all FOBT/FIT test use, and because recent evidence suggests that FOBT/FIT tests are rarely used properly [20]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Colorectal cancer (CRC) is the second leading cause of cancer death in the United States, and endoscopic screening can both detect and prevent cancer, but utilization is suboptimal and varies across geographic regions. We use multilevel regression to examine the various predictors of individuals' decisions to utilize endoscopic CRC screening. Study subjects are a 100% population cohort of Medicare beneficiaries identified in 2001 and followed through 2005. The outcome variable is a binary indicator of any sigmoidoscopy or colonoscopy use over this period. We analyze each state separately and map the findings for all states together to reveal patterns in the observed heterogeneity across states. We estimate a fully adjusted model for each state, based on a comprehensive socio-ecological model. We focus the discussion on the independent contributions of each of three community contextual variables that are amenable to policy intervention. Prevalence of Medicare managed care in one's neighborhood was associated with lower probability of screening in 12 states and higher probability in 19 states. Prevalence of poor English language ability among elders in one's neighborhood was associated with lower probability of screening in 15 states and higher probability in 6 states. Prevalence of poverty in one's neighborhood was associated with lower probability of screening in 36 states and higher probability in 5 states. There are considerable differences across states in the socio-ecological context of CRC screening by endoscopy, suggesting that the current decentralized configuration of state-specific comprehensive cancer control programs is well suited to respond to the observed heterogeneity. We find that interventions to mediate language barriers are more critically needed in some states than in others. Medicare managed care penetration, hypothesized to affect information about and diffusion of new endoscopic technologies, has a positive association in only a minority of states. This suggests that managed care plans' promotion of this cost-increasing technology has been rather limited. Area poverty has a negative impact in the vast majority of states, but is positive in five states, suggesting there are some effective cancer control policies in place targeting the poor with supplemental resources promoting CRC screening.
    Full-text · Article · Sep 2010 · International Journal of Health Geographics
  • [Show abstract] [Hide abstract]
    ABSTRACT: Whether to continue or discontinue warfarin before fecal occult blood testing (FOBT) requires comparison of the risks and benefits of both choices. Clinical practice varies on this issue, and guidelines are silent. A small body of evidence about the effect of warfarin on test characteristics of FOBT is inconclusive, although it suggests no effect. Retrospective studies on this topic may be prone to transfer bias, which affects the composition of the groups assembled for study. Considering the risks and benefits of discontinuing warfarin qualitatively, along with the published literature and clinical context in 2010, where tolerance for false-positive results is higher than it used to be and where immunochemical FOBT is a better screening test than older, guaiac-based FOBT, "no" seems like the "commonsense" answer.
    No preview · Article · Sep 2010 · The American Journal of Gastroenterology
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Primary care physicians (PCPs) play a key role in breast cancer screening, yet no current data exist regarding PCP practices. The authors analyzed a nationally representative survey of PCPs that was fielded during September 2006 to May 2007 to investigate PCP breast cancer screening beliefs, recommendations, and practices. Most of the 1212 PCPs who participated in the survey (80%) reported that mammography for average-risk women aged ≥ 50 years was very effective in reducing cancer mortality, and 54% reported that it was very effective for women ages 40 to 49 years. Fewer respondents reported that clinical breast examination (CBE) or breast self-examination (BSE) was very effective, but the majority rated CBE and BSE as somewhat effective. The majority of PCPs routinely recommended mammography, CBE, and BSE to patients aged ≥ 40 years. In multivariate models, family/general practitioners (odds ratio [OR], 2.23; 95% confidence interval [CI], 1.57-3.17 for mammography; OR, 4.42; 95% CI, 2.60-7.52 for CBE) and internal medicine specialists (OR, 3.21; 95% CI, 2.21-4.66 for mammography; OR, 5.34; 95% CI, 3.21-8.88 for CBE) were more likely to recommend an upper age limit for screening than obstetrician/gynecologists. Physicians who reported that US Preventive Services Task Force guidelines were very influential were more likely to recommend an age at which they no longer recommend mammography and CBE. To the authors' knowledge, the current study is the first national study in over 2 decades to report the breast cancer screening practices of PCPs and provides baseline data for monitoring the impact of changes in clinical practice guidelines. The current findings suggested that virtually all PCPs routinely recommend mammography, CBE, and BSE to their patients aged ≥ 40 years, although recommendations vary by primary care specialty.
    Full-text · Article · Jul 2011 · Cancer
Show more